DE202007000949U1 - Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke - Google Patents
Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke Download PDFInfo
- Publication number
- DE202007000949U1 DE202007000949U1 DE202007000949U DE202007000949U DE202007000949U1 DE 202007000949 U1 DE202007000949 U1 DE 202007000949U1 DE 202007000949 U DE202007000949 U DE 202007000949U DE 202007000949 U DE202007000949 U DE 202007000949U DE 202007000949 U1 DE202007000949 U1 DE 202007000949U1
- Authority
- DE
- Germany
- Prior art keywords
- omega
- fatty acid
- zinc
- magnesium
- fish oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000969 carrier Substances 0.000 title abstract 2
- 235000021323 fish oil Nutrition 0.000 title abstract 2
- 239000011777 magnesium Substances 0.000 title abstract 2
- 229910052749 magnesium Inorganic materials 0.000 title abstract 2
- 239000000463 material Substances 0.000 title abstract 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 title abstract 2
- 229940012843 omega-3 fatty acid Drugs 0.000 title abstract 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 title abstract 2
- 229940033080 omega-6 fatty acid Drugs 0.000 title abstract 2
- 239000011701 zinc Substances 0.000 title abstract 2
- 229910052725 zinc Inorganic materials 0.000 title abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 title 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000011785 micronutrient Substances 0.000 abstract 1
- 235000013369 micronutrients Nutrition 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE202007000949U DE202007000949U1 (de) | 2007-01-23 | 2007-01-23 | Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE202007000949U DE202007000949U1 (de) | 2007-01-23 | 2007-01-23 | Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE202007000949U1 true DE202007000949U1 (de) | 2007-04-12 |
Family
ID=37983157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE202007000949U Expired - Lifetime DE202007000949U1 (de) | 2007-01-23 | 2007-01-23 | Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE202007000949U1 (de) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009015879A1 (en) * | 2007-07-31 | 2009-02-05 | Fresenius Kabi Deutschland Gmbh | Cachexia prevention supplement |
| EP2143343A1 (de) * | 2008-07-11 | 2010-01-13 | Madeleine Portwood | Lernverbesserung |
| EP2130533A4 (de) * | 2007-04-05 | 2010-04-21 | J Oil Mills Inc | Ataraktikum und funktionelles nahrungsmittel |
| EP2384648A1 (de) * | 2010-05-07 | 2011-11-09 | Deenox SAS | Neue Zusammensetzungen mit omega 3 und Verwengung mit Kater-Linderung |
| WO2012030208A1 (en) * | 2010-09-03 | 2012-03-08 | N.V. Nutricia | Method and preparation for the treatment or prevention of anxiety or neurogenesis |
| WO2014174468A3 (es) * | 2013-04-23 | 2014-12-31 | Siegfried Rhein S.A. De C.V. | Composición de ácidos grasos omega-3, zinc y hierro para el tratamiento del trastorno por déficit de atención e hiperactividad (tdah) |
| US20150044138A1 (en) * | 2012-03-02 | 2015-02-12 | N.V. Nutricia | Method for improving functional synaptic connectivity |
| CN105192699A (zh) * | 2015-09-30 | 2015-12-30 | 深圳市生命力生物保健科技江苏有限公司 | 一种鱼油软胶囊及其制备方法 |
| WO2018176150A1 (en) * | 2017-03-29 | 2018-10-04 | Bioflash Inc. | Fish egg extracts, omega-3 lipid-based compositions and uses thereof |
-
2007
- 2007-01-23 DE DE202007000949U patent/DE202007000949U1/de not_active Expired - Lifetime
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2130533A4 (de) * | 2007-04-05 | 2010-04-21 | J Oil Mills Inc | Ataraktikum und funktionelles nahrungsmittel |
| US7951844B2 (en) | 2007-04-05 | 2011-05-31 | J-Oil Mills, Inc. | Tranquilizer and functional food |
| WO2009015879A1 (en) * | 2007-07-31 | 2009-02-05 | Fresenius Kabi Deutschland Gmbh | Cachexia prevention supplement |
| EP2025248A1 (de) * | 2007-07-31 | 2009-02-18 | Fresenius Kabi Deutschland GmbH | Zubehör zur Verhinderung von Abmagerungen |
| EP2143343A1 (de) * | 2008-07-11 | 2010-01-13 | Madeleine Portwood | Lernverbesserung |
| EP2384648A1 (de) * | 2010-05-07 | 2011-11-09 | Deenox SAS | Neue Zusammensetzungen mit omega 3 und Verwengung mit Kater-Linderung |
| WO2012030208A1 (en) * | 2010-09-03 | 2012-03-08 | N.V. Nutricia | Method and preparation for the treatment or prevention of anxiety or neurogenesis |
| CN103200830A (zh) * | 2010-09-03 | 2013-07-10 | N·V·努特里奇亚 | 用于治疗或预防焦虑或神经发生的方法和制剂 |
| US20150044138A1 (en) * | 2012-03-02 | 2015-02-12 | N.V. Nutricia | Method for improving functional synaptic connectivity |
| WO2014174468A3 (es) * | 2013-04-23 | 2014-12-31 | Siegfried Rhein S.A. De C.V. | Composición de ácidos grasos omega-3, zinc y hierro para el tratamiento del trastorno por déficit de atención e hiperactividad (tdah) |
| CN105192699A (zh) * | 2015-09-30 | 2015-12-30 | 深圳市生命力生物保健科技江苏有限公司 | 一种鱼油软胶囊及其制备方法 |
| WO2018176150A1 (en) * | 2017-03-29 | 2018-10-04 | Bioflash Inc. | Fish egg extracts, omega-3 lipid-based compositions and uses thereof |
| US11439614B2 (en) | 2017-03-29 | 2022-09-13 | Bioflash Inc. | Fish egg extracts, omega-3 lipid-based compositions and uses thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE202007000949U1 (de) | Nahrungsergänzungsmittel, bilanzierte Diät oder Arzneimittel für besonders medizinische Zwecke | |
| AU2018260866A1 (en) | Selective reduction of allelic variants | |
| DE602008002843D1 (de) | Neue antimikrobielle verbindungen, ihre synthese und ihre verwendung zur behandlung von säugetierinfektionen | |
| EA201100094A1 (ru) | Тиадиазолилоксифениламидины и их применение в качестве фунгицидов | |
| AP2010005462A0 (en) | Harmful organism control composition, and method for control of harmful organisms. | |
| BRPI0812427A2 (pt) | Método para paroduzir um produto de fermentação de material contendo lignocelulose, e, processo para produzir um produto de fermentação de uma combinação de material contendo amido e material contendo lignocelulose. | |
| PT1913001E (pt) | (r)-n-metilnaltrexona, processos para a sua síntese e sua utilização farmacêutica | |
| WO2011079902A3 (en) | Biological inhibitors of ror1 capable of inducing cell death | |
| PL2162143T3 (pl) | Mikroorganizmy mleka ssaków, kompozycje je zawierające i ich zastosowanie w leczeniu zapalenia sutka | |
| BRPI0814941A2 (pt) | Composição de tratamentode semente, e, método de tratamento de semente. | |
| WO2007109097A3 (en) | RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF | |
| MX350510B (es) | Aminación (r)-selectiva. | |
| EA201100093A1 (ru) | Тиадиазолилоксифениламидины и применение их в качестве фунгицидов | |
| BRPI1006145A2 (pt) | "composição e método para tratamento de diabetes". | |
| BRPI0910359A2 (pt) | método para inibir o crescimento de microorganismos e composição biocida | |
| SG10201912614RA (en) | Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same | |
| ATE494384T1 (de) | L-zystein-produzierendes bakterium und verfahren zur herstellung von l-zystein | |
| UA92625C2 (ru) | Бифенилкарбоксамиды и средство на их основе для борьбы с микроорганизмами | |
| WO2008094687A3 (en) | Gep, a novel chondrogenic growth factor and target in cartilage disorders | |
| MX2009006812A (es) | Moduladores del receptor c3a y metodos de uso de los mismos. | |
| EP2363480A3 (de) | Modulierung der Glukokortikoid-Rezeptor-Expression | |
| WO2012034118A3 (en) | Process for the treatment of biological materials and wastewater | |
| BRPI0814633A2 (pt) | Composição de matéria, composição curável anaeróbica, produtos de reação, processo para a preparação de um produto de reação a partir de uma composição curável anaeróbica, e, ligação. | |
| TW200833248A (en) | Bisoximes as fungicides | |
| WO2015058306A8 (fr) | Systeme et procede de biofiltration pour le traitement combine et simultane de methane et de lixiviat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R207 | Utility model specification |
Effective date: 20070516 |
|
| R150 | Term of protection extended to 6 years |
Effective date: 20100113 |
|
| R082 | Change of representative |
Representative=s name: BRIDTS NEBL, DE |
|
| R081 | Change of applicant/patentee |
Owner name: KRANICH PHARMA GMBH, DE Free format text: FORMER OWNER: LUKAS VOGEL,KLAUS WERNER HEUSCHEN,ADAM ALFRED, , DE Effective date: 20121026 Owner name: KRANICH PHARMA GMBH, DE Free format text: FORMER OWNERS: VOGEL, LUKAS, DR., 80634 MUENCHEN, DE; HEUSCHEN, KLAUS WERNER, 80639 MUENCHEN, DE; ALFRED, ADAM, DR., 80639 MUENCHEN, DE Effective date: 20121026 |
|
| R082 | Change of representative |
Representative=s name: BRIDTS NEBL, DE Effective date: 20121026 Representative=s name: VOSSIUS & PARTNER, DE Effective date: 20121026 Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE Effective date: 20121026 |
|
| R082 | Change of representative |
Representative=s name: VOSSIUS & PARTNER, DE Representative=s name: VOSSIUS & PARTNER PATENTANWAELTE RECHTSANWAELT, DE |
|
| R151 | Term of protection extended to 8 years |
Effective date: 20130123 |
|
| R152 | Term of protection extended to 10 years | ||
| R152 | Term of protection extended to 10 years |
Effective date: 20141201 |
|
| R071 | Expiry of right |